Overview

A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the short-term efficacy and safety of Fluoxetine in Japanese adult participants with Major Depressive Disorder (MDD).
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Fluoxetine